Bronchiolitis Completed Phase 3 Trials for Montelukast (DB00471)

IndicationStatusPhase
DBCOND0013705 (Bronchiolitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00076973An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)Treatment